Business, 15.06.2021 03:40 yair7

AUDITING: Covalon Technologies Ltd is an incorporated public company. Its principal business is to research, develop, and manufacture various patent-protected medical products that heals or improves infections, tissue repair, wound care, and surgical procedures; This industry has a low level concentration, without the monopoly of any big firm (Government of Canada). Besides this, Covalon is marketing and selling its products nationally and worldwide.

The Company generates its revenues through development contracts, licensing agreements, distribution contracts, and sales of two major product categories: patented products labeled with the Company’s name, and medical products for other medical companies under development and license contracts.

The global market projects the increase of the demand for those products due to the aging population, and the profits will reach over USD 75 billion by 2026. In 2020, North America accounted for the largest share of the infection control and wound care markets (Cision, 2021)(Fortune Business insights, 2020). However, one of the biggest issues is the ability of Canadian companies to compete with other countries because of factors like cost, availability of skilled employees, and market attractiveness. Adding the reliance to the overseas suppliers which makes the supply chain vulnerable to disruptions risk. Recently, Covalon started expanding its contracts to the Middle East and Latin America where legislation encourages foreign businesses to enter their markets, especially the medical device one (Government of Canada).
The company invests in R&D and acquires new technologies to stay competitive. Covalon Technologies Ltd. is” ISO 13485: 2016[1], MDSAP[2] and FDA QSR[3] certified, and follows strict GMP processes to support product development from concept to scalable market release” (Covalon, 20210. The federal government funds health-related research programs and offers “The Canadian Scientific Research and Experimental Development (SR&ED) tax incentive program” to encourage Canadian businesses to conduct R&D in Canada by providing claimants with cash refunds and/or tax credits for their expenditures on R&D (Government of Canada).

The Company is listed on the TSX, having the symbol COV. The Company also trades on the OTCQX Best Market, having the symbol of CVALF. The address of the Company’s corporate office and principal place of business is 1660 Tech Avenue, Unit 5, Mississauga, Ontario, Canada.

QUESTION:
Perform a fraud risk assessment and give 5 key fraud risks for this company along with overall conclusion on fraud risk level.

Please do not send any link.

Answers: 3

Show answers

Another question on Business

Business, 22.06.2019 08:50

Comprehensive illustrative problem: mira's store on february 1 20a4 mica delaman opened astore that sells school supplies her main customer are the students and teachers of happy students school that is situated in front of her store. mira wanted to know the financial position of mira's store. mira knew you were studying accounting. so she asked for . 1. to start her business mira's opened a checking account in the name of mira's store . the statement of account from the bank shows that the checking account has a balance of 31,535 of december 31,20a4

Answers: 2

Answer

Business, 22.06.2019 09:00

How does the plaintiff, mrs. wood, try to implicate the gun manufacturer ( who testifies, what do they say, what evidence is introduced)?

Answers: 2

Answer

Business, 22.06.2019 11:40

Fanning company is considering the addition of a new product to its cosmetics line. the company has three distinctly different options: a skin cream, a bath oil, or a hair coloring gel. relevant information and budgeted annual income statements for each of the products follow. skin cream bath oil color gel budgeted sales in units (a) 110,000 190,000 70,000 expected sales price (b) $8 $4 $11 variable costs per unit (c) $2 $2 $7 income statements sales revenue (a × b) $880,000 $760,000 $770,000 variable costs (a × c) (220,000) (380,000) (490,000) contribution margin 660,000 380,000 280,000 fixed costs (432,000) (240,000) (76,000) net income $228,000 $140,000 $204,000 required: (a) determine the margin of safety as a percentage for each product. (b) prepare revised income statements for each product, assuming a 20 percent increase in the budgeted sales volume. (c) for each product, determine the percentage change in net income that results from the 20 percent increase in sales. (d) assuming that management is pessimistic and risk averse, which product should the company add to its cosmetics line? (e) assuming that management is optimistic and risk aggressive, which product should the company add to its cosmetics line?

Answers: 1

Answer

Business, 22.06.2019 19:30

Which of the following constitute the types of unemployment occurring at the natural rate of unemployment? a. frictional and cyclical unemployment.b. structural and frictional unemployment.c. cyclical and structural unemployment.d. frictional, structural, and cyclical unemployment.

Answers: 2

Answer

You know the right answer?

AUDITING: Covalon Technologies Ltd is an incorporated public company. Its principal business is to...

Questions